Non-semaglutide GLP-1 medications from Henry Meds Henry offers two other GLP-1 RAs in addition to semaglutide: Tirzepatide: the active ingredient in Mounjaro and Zepbound Liraglutide: the active ingredient in Saxenda and Victoza Of the three drugs, tirzepatide has shown the highest weight loss rates in studies, with one study showing nearly 18% of body weight lost after 72 weeks
Retatrutide is Eli Lillys once weekly injectable that targets three pathways at the same time, GLP-1, GIP, and glucagon
Renal Insufficiency DPP-4 inhibitors have also been examined in placebo-controlled studies in subjects with type 2 diabetes and chronic renal insufficiency, including patients with end-stage renal disease on dialysis (118121)
Among these new therapeutic options, tirzepatide has gathered significant interest in the scientific and medical community as the first member of a new class of drugs characterized by their ability to selectively bind and activate the receptors for the intestinal hormones GIP and GLP-1
A unique and catchy name can set you apart
Metabolic mechanisms MOTS-c enhances insulin sensitivity through AMPK pathway activation, the master regulator of cellular energy homeostasis